Copyright
©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1688-1698
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1688
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1688
Interpretation | Test | Site (s) | Function |
Hepatocellular integrity | ALT | Hepatocyte (main), cardiac, renal and muscle tissue to smaller extent | Amino acid catabolism. Glutamate and pyruvate production for ATP production |
AST | Hepatocyte, cardiac, muscle and brain tissue | ||
LDH | Nonspecific, present widely in the body | Anaerobic glycolysis major enzyme in addition to NADH production. Significant in ischemic hepatitis | |
Cholestatic pattern | ALP | Hepatobiliary tract, bone, placenta and intestines | Dephosphorylation reactions. Role in bile production |
GGT | Mainly in hepatobiliary tract, present in multiple other organs (nonspecific as an isolate test) | Aids in identification of elevated ALP of biliary origin | |
5’nucleotidase | Nonspecific, present widely in the body | Clinical value in hepatobiliary and cholestatic disease specifically when paired with ALP and GGT | |
Bilirubin | Serum and liver | End product of heme breakdown. Exists in conjugated and unconjugated form. Elevation in conjugated suggestive of possible cholestasis | |
Synthetic function | Albumin | Serum | Main protein in the serum, maintains oncotic pressure. Produced by the liver |
PT/INR | Test to measure extrinsic coagulation pathway | Clotting factors primarily produced in the liver. Helpful however does not reflect true coagulation status |
- Citation: Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S. Abnormal liver enzymes: A review for clinicians. World J Hepatol 2021; 13(11): 1688-1698
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1688.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1688